DK141432B - Fremgangsmåde til fremstilling af intravenøst indgivelige immunoglobulinderivater. - Google Patents

Fremgangsmåde til fremstilling af intravenøst indgivelige immunoglobulinderivater. Download PDF

Info

Publication number
DK141432B
DK141432B DK93475AA DK93475A DK141432B DK 141432 B DK141432 B DK 141432B DK 93475A A DK93475A A DK 93475AA DK 93475 A DK93475 A DK 93475A DK 141432 B DK141432 B DK 141432B
Authority
DK
Denmark
Prior art keywords
immunoglobulin
reaction
chains
sulfonated
disulfide bonds
Prior art date
Application number
DK93475AA
Other languages
Danish (da)
English (en)
Other versions
DK141432C (2
DK93475A (2
Inventor
Yasuhiko Masuho
Sachio Ishimoto
Katsuhiko Tomibe
Kimihiko Matsuzawa
Kazuo Satake
Tsuneo Watanabe
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2634174A external-priority patent/JPS5417721B2/ja
Priority claimed from JP7127474A external-priority patent/JPS511630A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DK93475A publication Critical patent/DK93475A/da
Publication of DK141432B publication Critical patent/DK141432B/da
Application granted granted Critical
Publication of DK141432C publication Critical patent/DK141432C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK93475AA 1974-03-08 1975-03-07 Fremgangsmåde til fremstilling af intravenøst indgivelige immunoglobulinderivater. DK141432B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2634174A JPS5417721B2 (2) 1974-03-08 1974-03-08
JP2634174 1974-03-08
JP7127474A JPS511630A (ja) 1974-06-24 1974-06-24 Jomyakuchushayomenekiguroburinno seizoho
JP7127474 1974-06-24

Publications (3)

Publication Number Publication Date
DK93475A DK93475A (2) 1975-09-09
DK141432B true DK141432B (da) 1980-03-17
DK141432C DK141432C (2) 1980-09-15

Family

ID=26364115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93475AA DK141432B (da) 1974-03-08 1975-03-07 Fremgangsmåde til fremstilling af intravenøst indgivelige immunoglobulinderivater.

Country Status (12)

Country Link
US (1) US4059571A (2)
CA (1) CA1041997A (2)
CH (1) CH614426A5 (2)
DD (1) DD118655A5 (2)
DE (2) DE2560155C2 (2)
DK (1) DK141432B (2)
FR (1) FR2262996B1 (2)
GB (1) GB1497928A (2)
IN (1) IN138636B (2)
NL (1) NL167167C (2)
NO (1) NO144111C (2)
SE (1) SE403703B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151610B (da) * 1976-12-23 1987-12-21 Behringwerke Ag Fremgangsmaade til fremstilling af human-immunoglobulinpraeparater med formindsket komplementaktivitet og god antistofaktivitet

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
CH644131A5 (en) * 1979-05-23 1984-07-13 Teijin Ltd Process for the preparation of immunogammaglobulin
US4362661A (en) * 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
CA1153695A (en) * 1979-08-30 1983-09-13 Syoji Ono S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
JPS56113713A (en) * 1980-02-14 1981-09-07 Chemo Sero Therapeut Res Inst Preparation of immunoglobulin with high content of monomer
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
JPH05506218A (ja) * 1990-05-07 1993-09-16 イムノメデイツクス・インコーポレイテツド 一価の抗体フラグメントの改良された放射性標識方法
AU2004210679A1 (en) * 2003-02-10 2004-08-26 Elan Pharmaceuticals, Inc. Immunoglobulin formulation and method of preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151610B (da) * 1976-12-23 1987-12-21 Behringwerke Ag Fremgangsmaade til fremstilling af human-immunoglobulinpraeparater med formindsket komplementaktivitet og god antistofaktivitet

Also Published As

Publication number Publication date
DK141432C (2) 1980-09-15
FR2262996A1 (2) 1975-10-03
SE7502346L (sv) 1975-09-09
DE2560155C2 (de) 1984-04-26
NO144111B (no) 1981-03-16
SE403703B (sv) 1978-09-04
DE2508132B2 (de) 1980-02-21
DE2508132C3 (de) 1980-10-16
NO750768L (2) 1975-09-09
DE2508132A1 (de) 1975-09-11
IN138636B (2) 1976-03-06
US4059571A (en) 1977-11-22
NL167167B (nl) 1981-06-16
CA1041997A (en) 1978-11-07
NL7502745A (nl) 1975-09-10
FR2262996B1 (2) 1982-01-29
GB1497928A (en) 1978-01-12
CH614426A5 (2) 1979-11-30
DK93475A (2) 1975-09-09
NL167167C (nl) 1981-11-16
AU7872975A (en) 1976-09-09
DD118655A5 (2) 1976-03-12
NO144111C (no) 1981-06-24

Similar Documents

Publication Publication Date Title
JP6612186B2 (ja) 抗体調製物
US4396608A (en) Intravenously injectable immune serum globulin
US4499073A (en) Intravenously injectable immune serum globulin
FI66534B (fi) Foerfarande foer framstaellning av immunoglobulin som innehaoller antikroppar och aer laempligt foer intravenoes administration
DE2548636A1 (de) Antiseren und antikoerper mit spezifischer wirkung gegen krebszellenproteine, verfahren zu ihrer herstellung und arzneipraeparate
RU2008916C1 (ru) Способ пастеризации водного раствора иммуноглобулина
IL192289A (en) Immunoglobulin g (igg) concentrate with reduced levels of anti- a and anti-b antibodies
EP0143413A2 (de) Digitalis-Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von Digitalis-Intoxikationen
CA1041997A (en) Immunoglobulin derivatives and process for the preparation thereof
JPH0639388B2 (ja) 免疫グロブリン−ｇ−含有フラクシヨン
Besarab et al. Effect of albumin and free calcium concentrations on calcium binding in vitro.
EP0764447B1 (en) Preparation of virally inactivated intravenously injectable immune serum globulin
Samuel Antibodies reacting with salmon and human protamines in sera from infertile men and from vasectomized men and monkeys
US4479934A (en) Method and agent for the therapy of immunocomplex diseases
Huertas et al. Clinical effects of immunization, bleeding, and albumin-based fluid therapy in horses used as immunoglobulin source to produce a polyspecific antivenom (Echitab-plus-ICP) towards venoms of African snakes
US4911910A (en) Purified equine immunologlobulins and method of use thereof
CS195693B2 (cs) Způsob přípravy imunaglobulinových derivátů
Ishizaka et al. Molecular Bases of Passive Sensitization: I. Role of Disulfide Linkages in γ-Globulin Molecule
Orlans et al. Clostridium welchii: Epsilon-Toxin and Antitoxin
Hektoen et al. Progressive, Selective Absorption of Precipitins in Multivalent Serum
WO2001044298A1 (en) Improvement of therapeutic potential of immunoglobulin preparations
Huertas Segura et al. Clinical effects of immunization, bleeding, and albumin-based fluid therapy in horses used as immunoglobulin source to produce a polyspecific antivenom (Echitab-plus-ICP) towards venoms of African snakes
JPS5846488B2 (ja) スルホ化ヒト免疫グロブリンの製造法
JPS58139068A (ja) イバラキ病赤血球凝集抑制反応用抗原の作成法
Crawford Low molecular weight proteinuria and the natural history of multiple myeloma.

Legal Events

Date Code Title Description
PUP Patent expired